Neoadjuvant chemoradiotherapy (NACRT) in patients with locally advanced rectal cancer (RC): Results of a phase I/II trial in Japan.

e14670 Background: NACRT for patients with RC has been shown to increase the chance of sphincter preservation and local control, and has become the standard of care in stage T3/T4 rectal carcinoma ...